Variable |
Length of Stay |
RR |
95% CI |
P value |
< 4 days |
≥4 days
|
Mortality |
– |
– |
– |
– |
– |
Yes |
6 (15.8%) |
32 (84.2%) |
1.125 |
0.424-2.985 |
0.813 |
No |
8 (14.0%) |
49 (86.0%) |
– |
– |
– |
Appropriate use during initiation |
– |
– |
– |
– |
– |
Appropriate |
12 (15.8%) |
64 (84.2%) |
1.500 |
0.366-6.144 |
0.563 |
Not Appropriate |
2 (10.5%) |
17 (89.5%) |
– |
– |
– |
Appropriate use during continuation |
– |
– |
– |
– |
– |
Appropriate |
13 (19.4%) |
54 (80.6%) |
1.196 |
1.043-1.373 |
0.047 |
Not Appropriate |
1 (3.6%) |
27 (96.4%) |
– |
– |
– |
Pattern of bacteria |
– |
– |
– |
– |
– |
Positive gram |
5 (15.2%) |
28 (84.8%) |
1.023 |
0.304-3.438 |
0.971 |
Negative gram |
4 (14.8%) |
23 (85.2%) |
– |
– |
– |
Compatibility of Continuation antibiotic |
– |
– |
– |
– |
– |
Compatibility |
12 (20.3%) |
47 (79.7%) |
3.661 |
0.869-15.428 |
0.049 |
Not Compatibility |
2 (5.6%) |
34 (94.4%) |
– |
– |
– |